Detalhe da pesquisa
1.
Combining targeted DNA repair inhibition and immune-oncology approaches for enhanced tumor control.
Mol Cell
; 83(5): 660-680, 2023 03 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36669489
2.
Clinical insights into small cell lung cancer: Tumor heterogeneity, diagnosis, therapy, and future directions.
CA Cancer J Clin
; 73(6): 620-652, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37329269
3.
Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin.
Cell
; 158(4): 929-944, 2014 Aug 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-25109877
4.
Metabolic Diversity in Human Non-Small Cell Lung Cancer Cells.
Mol Cell
; 76(5): 838-851.e5, 2019 12 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31564558
5.
Author Correction: CPS1 maintains pyrimidine pools and DNA synthesis in KRAS/LKB1-mutant lung cancer cells.
Nature
; 569(7756): E4, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-31043737
6.
CPS1 maintains pyrimidine pools and DNA synthesis in KRAS/LKB1-mutant lung cancer cells.
Nature
; 546(7656): 168-172, 2017 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28538732
7.
Dynamic expression of Schlafen 11 (SLFN11) in circulating tumour cells as a liquid biomarker in small cell lung cancer.
Br J Cancer
; 127(3): 569-576, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35440668
8.
DLL3 as an Emerging Target for the Treatment of Neuroendocrine Neoplasms.
Oncologist
; 27(11): 940-951, 2022 11 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35983951
9.
The role of Schlafen 11 (SLFN11) as a predictive biomarker for targeting the DNA damage response.
Br J Cancer
; 124(5): 857-859, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33328609
10.
HIRA deficiency in muscle fibers causes hypertrophy and susceptibility to oxidative stress.
J Cell Sci
; 130(15): 2551-2563, 2017 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28600325
11.
eIF2ß, a subunit of translation-initiation factor EIF2, is a potential therapeutic target for non-small cell lung cancer.
Cancer Sci
; 109(6): 1843-1852, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29624814
12.
Comparative study of lung and extrapulmonary poorly differentiated neuroendocrine carcinomas: A SEER database analysis of 162,983 cases.
Cancer
; 124(4): 807-815, 2018 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29211313
13.
Rovalpituzumab tesirine, a DLL3-targeted antibody-drug conjugate, in recurrent small-cell lung cancer: a first-in-human, first-in-class, open-label, phase 1 study.
Lancet Oncol
; 18(1): 42-51, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27932068
14.
Identification of proteasomal catalytic subunit PSMA6 as a therapeutic target for lung cancer.
Cancer Sci
; 108(4): 732-743, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28165654
15.
drexplorer: A tool to explore dose-response relationships and drug-drug interactions.
Bioinformatics
; 31(10): 1692-4, 2015 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25600946
16.
Sequencing of mutational hotspots in cancer-related genes in small cell neuroendocrine cervical cancer.
Gynecol Oncol
; 141(3): 588-591, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27079212
17.
Beyond chemotherapy: Emerging biomarkers and therapies as small cell lung cancer enters the immune checkpoint era.
Cancer
; 125(4): 496-498, 2019 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30620399
18.
Progress in the management of limited-stage small cell lung cancer.
Cancer
; 120(6): 790-8, 2014 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24327434
19.
Management of the lymph node-positive neck in the patient with human papillomavirus-associated oropharyngeal cancer.
Cancer
; 120(19): 3082-8, 2014 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24898672
20.
Clinical Pharmacology Profile of AMG 119, the First Chimeric Antigen Receptor T (CAR-T) Cell Therapy Targeting Delta-Like Ligand 3 (DLL3), in Patients with Relapsed/Refractory Small Cell Lung Cancer (SCLC).
J Clin Pharmacol
; 64(3): 362-370, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37694295